P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL)

Detalles Bibliográficos
Autores principales: Munoz, Javier, Locke, Frederick, Lekakis, Lazaros, Eradat, Herbert, Tees, Michael, de Vos, Sven, Nath, Rajneesh, Stevens, Don, Malik, Shahbaz, Popplewell, Leslie, Hamadani, Mehdi, Oluwole, Olalekan, Perales, Miguel-Angel, Miklos, David, Fisher, Paul, Goyal, Lovely, Navale, Lynn, Kaufman, Gregory, Kai, Kazuharu, Balakumaran, Arun, Neelapu, Sattva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430976/
http://dx.doi.org/10.1097/01.HS9.0000971396.88082.64

Ejemplares similares

Ejemplares similares